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A successful HIV vaccine must elicit immune
responses which recognize variants of HIV circu-
lating in the vaccine target population.  It is there-
fore important to understand HIV genetic and an-
tigenic variation in geographic areas where vac-
cine trials are anticipated.
In 1991, Carrow et al. published the observa-
tion that, like American and African sera, Brazil-
ian HIV+ sera reacted extensively with the V3  re-
gion of the MN strain of HIV.  These Brazilian
sera also readily neutralized HIV-MN (EW Carrow
et al. 1991 AIDS Res Human Retrovir 7: 831-837).
In 1993, Potts et al. reported sequence heteroge-
neity in the V3 region of Brazilian isolates.  Based
on overall V3 sequences, the majority of Brazilian
isolates were more similar to those of North
America and Haiti than to African isolates.  How-
ever, only 59% of isolates contained proline in the
tip of the V3 loop.  In this small study, 40% con-
tained a GPGR motif while 36% contained a
GWGR motif – previously reported in some Japa-
nese isolates (KE Potts et al. 1993 AIDS 7: 1191-
1197).
In 1994, Morgado et al. studied isolates from
Rio de Janeiro and São Paulo, and identified one
subtype F isolate and a putative B/F recombinant.
In this study, octameric sequences at the tip of the
Brazilian subtype B sequences were variable and
distinct from those in North America and Europe.
The GPGR motif was found in only 28.5% of the
isolates, and GWGR in 43% (M Morgado et al.
1994 AIDS Res Human Retrovir 10: 569-576).
Divergence throughout the V3 region suggested
that Brazilian isolates might  also differ antigeni-
cally from prototype subtype B strains (upon which
most experimental HIV vaccines are being based).
Sequence analysis, and to a lesser extent het-
eroduplex mobility analysis, are labor-intensive,
and, in any case, possible only when viral isolates
or patient PBMCs are available.  We therefore un-
dertook a study of antibody binding to defined V3
peptides, using Brazilian sera including many from
patients from whom no sequenced isolates were
available.
Sequences of the four peptides used in this study
are compared with that of the B subtype consen-
sus sequence in Fig.  BR1 differs from the subtype
B consensus only by substitution of “W” in place
of “P” in the GPGR motif.   BR2 is a consensus of
a group of Brazilian isolates which possess the
GWGR motif.  Overall, two of the peptides in-
cluded “P” in the V3 tip motif and two included
“W”. The peptides were biotinylated at their amino
terminus and contained a four amino acid spacer.
The biotinylated peptides were captured onto avi-
din coated microtiter plates.
Sequence of the synthetic peptides used.
Sera were obtained initially from 21 Brazilian
patients whose HIV isolates were of known V3
sequence.  Binding of these sera to the peptides
was determined colorimetrically using an enzyme-
labeled anti-human-immunoglobulin and a chro-
mogenic substrate.  Binding was expressed as the
reciprocal of the highest antibody dilution giving
an optical density of 0.5.  Serum specimens corre-
sponding to the GWGR motif had highest titers
against the GWGR-containing BR-1 and BR-2
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peptides.  Specimens  corresponding to isolates
with “P” in the motif, had titers that were more
nearly equal against most of the peptides.
Four different ratios of binding titers (BR1-to-
SF2, BR1-to-MN, BR2-to-SF2 and BR2-to-MN)
were computed.  The sum of these four ratios would
thus be expected to be high for reactivity with the
“W” motif and low for reactivity with the “P” motif.
By inspection of the data, we found that ratio-sums
above 16 corresponded 100% with “W” reactivity
and ratio-sums below 8 corresponded 100% with
“P” reactivity.  Ratios between 8 and 16 were con-
sidered indeterminate.  Of five specimens with
unusual non-W/non-P motifs, two typed by this
scheme as “W-like”, one as “P-like” and one as
indeterminate.
As shown in Table, the ratio-sum technique was
applied to sera from Rio de Janeiro, Bahia and São
Paulo from patients with no sequenced isolates
available.  Overall, there were equal numbers of
GWGR and GPGR types.  While not statistically
significant, GPGR predominated in the northern-
most region (Bahia), GWGR predominated in the
southernmost area (São Paulo), and there were
equal numbers in Rio de Janeiro, which lies geo-
graphically between the other two sites.  Data for
São Paulo are shown for equal numbers of samples
collected recently and 10 years earlier.  Since there
is no significant difference between these, it sug-
gests that GWGR was already common in Brazil
early in the epidemic.  This early, uncommon
GWGR strain may thus be a phylogenetic ances-
tor of current GWGR strains.
Geometric mean averages of binding titers
against each of the six peptides were computed
separately for all P-type and for all W-type antis-
era.  In the case of peptides BR2, SF2 and MN,
titer differences were especially statistically sig-
nificant.  It is interesting that titers of P-type speci-
mens were especially high against the consensus
F-type peptide, in contrast to those of W-type pep-
tides.  This is consistent with the “promiscuous”,
or relatively broad, reactivity of P-type antisera.
These observations suggest that the choice of a
GPGR motif strain, such as MN, as the basis for a
vaccine may be fortuitous — even in an area such
as Brazil where multiple HIV subtypes and V3-
motif variants coexist.  In the context of vaccine
development, however, the important issue is the
ability of an HIV antigen to elicit broad functional
activities such as virus neutralization or HIV-spe-
cific cytotoxic T-lymphocytes.  Neutralizations of
a Brazilian motif-W virus and a Brazilan motif-P
were therefore studied.  For type-W sera, there was
a strong selectivity for neutralization of type-W
virus, consistent with the antibody-binding data.
In contrast, neutralization of these same viruses by
type-P antisera overall occurred without preference
for either virus (data not shown).
In conclusion, (1) in Brazil there are subtype-
B viruses with different V3 motifs; (2) there are
two antigenically distinct strains of HIV-1 subtype
B cocirculating widely in Brazil; (3) antibody-pep-
tide binding experiments can categorize patients
exposed to HIV variants with different V3 motifs,
even in the absence of sequenced viral isolates; (4)
functional antibody activities, such as virus neu-
tralization, may be correlated with exposure to dif-
ferent V3 motifs; (5)  V3-motif analysis and pep-
tide-binding studies may be relevant to the design
of HIV vaccines.  For example, the GPGR motif
of HIV-MN may contribute to its eliciting a more
broadly cross-reactive response than would be the
case with subtype B viruses having other V3 mo-
tifs.
TABLE
Frequency of serologic reactivity to V3 synthetic
peptides in Brazilian sera
Number (%) of sera
Location Date GWGR GPGR Indeterminate Total
Bahia 1988-90 11(27) 27(66) 3(7) 41
Rio 1988-92 39(48) 37(46) 5(6) 81
São Paulo 1983 18(64) 10(36) 0 28
São Paulo 1993-94 15(54) 13(46) 0 28
Total 83(47) 87(49) 8(4) 178
